4//SEC Filing
Snisarenko John 4
Accession 0000899243-19-026639
CIK 0001720725other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:08 AM ET
Size
4.6 KB
Accession
0000899243-19-026639
Insider Transaction Report
Form 4
Snisarenko John
Chief Commercial Officer
Transactions
- Purchase
Common Stock, par value $0.001 per share
2019-11-04$16.00/sh+3,000$48,000→ 3,000 total
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001783264
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:08 AM ET
- Size
- 4.6 KB